Cargando…
Effects of the peripherally acting μ-opioid receptor antagonist methylnaltrexone on acute pancreatitis severity: study protocol for a multicentre double-blind randomised placebo-controlled interventional trial, the PAMORA-AP trial
BACKGROUND: Moderate to severe acute pancreatitis (AP) is associated with a high rate of complications and increased mortality, yet no targeted pharmacologic treatment currently exists. As pain is a dominant symptom in AP, patients are exposed to excess levels of both endo- and exogenous opioids, wh...
Autores principales: | Knoph, Cecilie Siggaard, Cook, Mathias Ellgaard, Fjelsted, Camilla Ann, Novovic, Srdan, Mortensen, Michael Bau, Nielsen, Liv Bjerre Juul, Hansen, Mark Berner, Frøkjær, Jens Brøndum, Olesen, Søren Schou, Drewes, Asbjørn Mohr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686628/ https://www.ncbi.nlm.nih.gov/pubmed/34924020 http://dx.doi.org/10.1186/s13063-021-05885-3 |
Ejemplares similares
-
Effects of a peripherally acting µ-opioid receptor antagonist for the prevention of recurrent acute pancreatitis: study protocol for an investigator-initiated, randomized, placebo-controlled, double-blind clinical trial (PAMORA-RAP trial)
por: Cook, Mathias E., et al.
Publicado: (2023) -
Spinal Excitability in Patients with Painful Chronic Pancreatitis
por: Knoph, Cecilie Siggaard, et al.
Publicado: (2023) -
Cervical transcutaneous vagal neuromodulation in chronic pancreatitis patients with chronic pain: A randomised sham controlled clinical trial
por: Muthulingam, Janusiya Anajan, et al.
Publicado: (2021) -
Study protocol for a randomised double-blinded, sham-controlled, prospective, cross-over clinical trial of vagal neuromodulation for pain treatment in patients with chronic pancreatitis
por: Muthulingam, Janusiya Anajan, et al.
Publicado: (2019) -
Study protocol for a randomised, double-blinded, placebo-controlled, clinical trial of S-ketamine for pain treatment in patients with chronic pancreatitis (RESET trial)
por: Juel, Jacob, et al.
Publicado: (2015)